Home » Topics » Conferences

Conferences
RSS

Preclinical studies with GPI-2A reported by Genesys Pharma

April 30, 1997

Potent, selective and orally active COX-2 inhibitors from Parke-Davis

April 30, 1997

ISIS-5320: preclinical study results

April 30, 1997

BMS-200475: profile of a novel anti-hepatitis B compound

April 30, 1997

Didox/Trimidox demonstrate antiretroviral activity in murine model

April 30, 1997

Preclinical results of IL-12 for chronic viral disease

April 30, 1997

Neuraminidase inhibitors highlighted at antiviral conference

April 29, 1997

Target of action of AR-177 elucidated

April 29, 1997

MDL-101731 shows potent antiviral activity in vitro

April 29, 1997

Potent antitumor farnesyltransferase inhibitors discovered by Parke-Davis

April 29, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...